Delayed Initiation of Olaparib Maintenance Therapy in Platinum Sensitive Recurrent Ovarian Cancer

Summary

The purpose of this study is to test if delaying the start of the olaparib until there is a rise in a tumor marker called CA-125 will result in a longer time until the next or different treatment for the patient's cancer. The study will also evaluate how delaying the start of maintenance therapy will affect symptoms; physical functioning; quality of life; and impact on finances.

Timeline

Start

2020-06-29

Primary completion

2023-05-31

Completion

2023-05-31

Outcome

Outcome not reported

Stopped (Enrollment): “Slow enrollment”

Drugs

Indications